Dr. Hannah Galantino-Homer has been appointed the senior research investigator of the newly created laminitis research initiative at the University of Pennsylvania School of Veterinary Medicine. Dr. Galantino-Homer will serve as a leading investigator in Penn Vet’s laminitis research efforts. The appointment was effective July 1.
“With this appointment of one of our best and brightest, Penn Vet reinforces its commitment to equine disease research,” said Dr. Joan C. Hendricks, the Gilbert S. Kahn Dean of Veterinary Medicine. “Dr. Galantino-Homer’s appointment is our first step in focusing and investing more time and funds in answering the fundamental questions of what causes laminitis and how it can be treated. Her expertise and vision will help us develop preventative and therapeutic management strategies for this devastating condition.”
Prior to her new appointment, Dr. Galantino-Homer was a lecturer and researcher in the Center for Animal Transgenesis and Germ Cell Research, located at Penn Vet’s New Bolton Center.
Dr. Galantino-Homer received her VMD from the School of Veterinary Medicine and her Ph.D. from the Biomedical Graduate Studies at Penn. Her undergraduate degree in biology and English literature is from Swarthmore College. Dr. Galantino-Homer, who attended the George School in Bucks County, is also a Diplomate of American College of Theriogenologists.
The new initiative will enhance work currently being done at Penn Vet in the area of equine disease research, which is funded in part by donors to the Laminitis Research Fund. Laminitis, a debilitating and painful condition of the hoof, is a silent killer that affects horses around the globe. Both the American Association of Equine Practitioners (AAEP) and the United States Department of Agriculture (USDA) list laminitis as the priority area for equine research and funding.
This post is from the University of Pennsylvania.
